Research programme: S-lansoprazole - Sepracor

Drug Profile

Research programme: S-lansoprazole - Sepracor

Alternative Names: (S)-lansoprazole

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Sepracor
  • Class
  • Mechanism of Action Proton pump inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Gastro-oesophageal reflux

Most Recent Events

  • 31 Aug 2006 Discontinued - Preclinical for Gastro-oesophageal reflux in USA (PO)
  • 18 Apr 2001 New profile
  • 18 Apr 2001 Preclinical development for Gastro-oesophageal reflux in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top